RP
TDOC icon

Riverbridge Partners’s Teladoc Health TDOC Stock Holding History

Riverbridge Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-255,014
Closed -$18.4M – 200
2022
Q1 		$18.4M Sell
255,014
-3,322
-1% -$239K 0.21% 94
2021
Q4 		$23.7M Sell
258,336
-20,128
-7% -$2.41M 0.23% 97
2021
Q3 		$35.3M Sell
278,464
-428
-0.2% -$62.3K 0.35% 88
2021
Q2 		$46.4M Buy
278,892
+103,793
+59% +$16.8M 0.47% 77
2021
Q1 		$31.8M Sell
175,099
-393,436
-69% -$91.3M 0.36% 86
2020
Q4 		$114M Buy
568,535
+20,969
+4% +$4.26M 1.26% 29
2020
Q3 		$120M Sell
547,566
-75,989
-12% -$16.1M 1.68% 20
2020
Q2 		$119M Sell
623,555
-286,127
-31% -$50.1M 1.87% 17
2020
Q1 		$141M Sell
909,682
-535,916
-37% -$62.3M 2.95% 3
2019
Q4 		$121M Sell
1,445,598
-305,187
-17% -$23.2M 2.17% 9
2019
Q3 		$119M Sell
1,750,785
-3,713
-0.2% -$244K 2.25% 9
2019
Q2 		$117M Buy
1,754,498
+230,937
+15% +$13.5M 2.2% 9
2019
Q1 		$84.7M Buy
1,523,561
+294,523
+24% +$18M 1.65% 19
2018
Q4 		$60.9M Buy
1,229,038
+390,365
+47% +$23.9M 1.27% 26
2018
Q3 		$72.4M Sell
838,673
-35,416
-4% -$2.52M 1.21% 30
2018
Q2 		$50.7M Sell
874,089
-11,070
-1% -$541K 0.91% 39
2018
Q1 		$35.7M Buy
885,159
+26,141
+3% +$987K 0.65% 56
2017
Q4 		$29.9M Buy
859,018
+262,959
+44% +$8.73M 0.58% 62
2017
Q3 		$19.8M Sell
596,059
-78,066
-12% -$2.56M 0.39% 81
2017
Q2 		$23.4M Buy
+674,125
New +$19.6M 0.45% 75

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Riverbridge Partners's TDOC Position: Q2 2022 in Review

Riverbridge Partners sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 255,014 shares — an estimated $18.4M sold.

Riverbridge Partners first reported a position in TDOC in Q2 2017 and held it in 20 quarters. The position peaked at $141M in Q1 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Riverbridge Partners reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Riverbridge Partners sold 255,014 Teladoc Health shares in Q2 2022, an estimated $18.4M.
  • Riverbridge Partners first reported a position in Teladoc Health in Q2 2017 and held it in 20 quarters.
  • Riverbridge Partners's Teladoc Health position peaked at $141M in Q1 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Riverbridge Partners's 13F filing for Q2 2022, filed 11 Jul 2022.